HEMOGENYX UK LIMITED

Company number 10118339

Date	Type	Description	View / Download
26 Apr 2018	CS01	Confirmation statement made on 11 April 2018 with updates	(7 pages)
29 Jan 2018	AA	Accounts for a dormant company made up to 30 April 2017	(2 pages) Download iXBRL
02 Nov 2017	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(1 page)
30 Oct 2017	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES13 ‐ Sub division 04/10/2017	(1 page)
20 Oct 2017	SH02	Sub-division of shares on 4 October 2017	(4 pages)
17 Oct 2017	AP01	Appointment of Dr Vladislav Sandler as a director on 4 October 2017	(2 pages)
17 Oct 2017	AP01	Appointment of Dr Robin William Campbell as a director on 4 October 2017	(2 pages)
17 Oct 2017	SH01	Statement of capital following an allotment of shares on 4 October 2017 GBP 221.33	(4 pages)
04 Oct 2017	RESOLUTIONS	Resolutions RES15 ‐ Change company name resolution on 2017-10-04	(3 pages)
04 Oct 2017	CONNOT	Change of name notice	(2 pages)
05 Jul 2017	DISS40	Compulsory strike-off action has been discontinued	(1 page)
04 Jul 2017	GAZ1	First Gazette notice for compulsory strike-off	(1 page)
30 Jun 2017	CS01	Confirmation statement made on 11 April 2017 with updates	(5 pages)
29 Jun 2017	PSC01	Notification of Lawrence Pemble as a person with significant control on 12 April 2016	(2 pages)
04 Jul 2016	AD01	Registered office address changed from 17 Cavendish Square London W1G 0PH United Kingdom to 5 Fleet Place London EC4M 7rd on 4 July 2016	(1 page)
12 Apr 2016	NEWINC	Incorporation Statement of capital on 2016-04-12 GBP 1	(32 pages)